BRASH syndrome stands for Bradycardia, Renal failure, Atrioventricular node blocker, Shock and Hyperkalaemia. The syndrome is characterised by a pentad of these clinical findings, and it is …

2022年9月1日 · Bradycardia, renal failure, atrioventricular (AV) nodal blockade, shock, and hyperkalemia (BRASH) syndrome is a recently-established entity precipitated by medication …

2023年6月1日 · Based on the pathophysiology of BRASH syndrome and our findings in this systematic review, a multi-faceted therapeutic approach addressing bradycardic shock, renal …

BRASH syndrome is a serious complication that warrants a high index of suspicion in patients with CKD or acute kidney injury who take an AVNB. Early recognition of this entity can help …

Background: Bradycardia, renal failure, atrioventricular (AV) nodal blockade, shock, and hyperkalemia (BRASH) syndrome is a recently-established entity precipitated by medication …

2023年3月4日 · BRASH syndrome describes a unique clinical presentation of a complication of commonly prescribed medication. Understanding and recognizing the pathophysiology of …

2019年12月20日 · BRASH syndrome is initiated by synergistic bradycardia due to the combination of hyperkalemia and medications that block the atrioventricular (AV) node. The …

The pathophysiology explains the degree of bradycardia seen in a patient with appropriate medication use and only moderate hyperkalemia. Here, we report a case of BRASH syndrome …

BRASH syndrome is characterized by bradycardia, renal failure, use of an atrioventricular nodal blocker (AVNB), shock, and hyperkalemia. These symptoms represent an ongoing vicious …

INTRODUCTION: BRASH syndrome is a newly recognized clinical entity characterized by bradycardia, renal failure, AV blockade, shock, and hyperkalemia. Patients with BRASH …